Stranded Technologies Podcast cover image

Ep. 99: A Conversation with Cremieux - How to Tell Good Science from Junk, and What’s Next in US Biotech & Deregulation

Stranded Technologies Podcast

00:00

Assets and modalities likely undervalued

Cremieux identifies siRNA and long-acting modalities (e.g., Lp(a) and PCSK9 targets) as underappreciated investment opportunities.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app